Can an epilepsy pill stop Alzheimer's before it starts?
NCT ID NCT07477431
Summary
This study is testing if very low doses of an existing epilepsy drug, levetiracetam, can calm down overactive brain signals in people who are at risk for Alzheimer's disease but don't yet have symptoms. It involves 40 adults in Toronto with a family history of Alzheimer's and minor memory concerns. Each participant will take the drug and a placebo for four weeks each, while researchers use brain scans to see if the drug normalizes brain activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIPPOCAMPAL HYPERACTIVATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Toronto Western Hospital
RECRUITINGToronto, Ontario, M5T 2S8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.